AMERICAN INTERNATIONAL GROUP, INC. - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 127 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$23,274
-57.2%
21,751
+3.7%
0.00%
Q2 2023$54,333
-31.8%
20,978
+7.5%
0.00%
-100.0%
Q1 2023$79,609
-17.1%
19,512
+2.0%
0.00%0.0%
Q4 2022$96,002
-61.1%
19,124
+1.3%
0.00%
-50.0%
Q3 2022$247,000
+5.1%
18,874
+2.8%
0.00%0.0%
Q2 2022$235,000
-1.7%
18,351
+17.3%
0.00%
+100.0%
Q1 2022$239,000
-19.5%
15,643
-6.6%
0.00%0.0%
Q4 2021$297,000
-18.0%
16,744
-2.9%
0.00%
-50.0%
Q3 2021$362,000
+4.0%
17,245
-2.3%
0.00%
+100.0%
Q2 2021$348,000
-20.2%
17,655
+17.7%
0.00%
-50.0%
Q1 2021$436,000
+3.8%
14,995
+8.2%
0.00%0.0%
Q4 2020$420,000
+85.0%
13,861
-2.8%
0.00%
+100.0%
Q3 2020$227,000
-19.8%
14,259
-0.7%
0.00%0.0%
Q2 2020$283,000
+59.0%
14,357
-0.7%
0.00%0.0%
Q1 2020$178,000
-37.1%
14,455
-5.5%
0.00%0.0%
Q4 2019$283,000
+371.7%
15,289
+254.3%
0.00%
Q3 2019$60,000
-4.8%
4,315
+0.9%
0.00%
Q2 2019$63,0004,2770.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,766,666$59,928,00049.90%
Greenspring Associates, LLC 1,573,357$25,032,00038.95%
Svennilson Peter 18,017,932$286,665,00023.39%
Aquilo Capital Management, LLC 1,018,334$16,202,0001.72%
Jasper Ridge Partners, L.P. 308,750$4,912,0000.28%
Samsara BioCapital, LLC 36,451$580,0000.16%
Rock Springs Capital Management LP 360,454$5,735,0000.15%
Point72 Asset Management, L.P. 1,611,850$25,645,0000.13%
Virtus ETF Advisers LLC 14,880$237,0000.12%
WELD CAPITAL MANAGEMENT LLC 15,238$242,0000.10%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders